{"id":545048,"date":"2026-08-14T13:42:21","date_gmt":"2026-08-14T13:42:21","guid":{"rendered":"https:\/\/www.newjerseyheadlines.com\/news\/story\/545048\/microcaps-toon-igc-surg-mdxh-to-watch-now-as-earnings-ai-and-biotech-catalysts-build.html"},"modified":"2026-08-14T13:42:21","modified_gmt":"2026-08-14T13:42:21","slug":"microcaps-toon-igc-surg-mdxh-to-watch-now-as-earnings-ai-and-biotech-catalysts-build","status":"publish","type":"post","link":"http:\/\/www.northcarolinaheadlines.com\/news\/story\/545048\/microcaps-toon-igc-surg-mdxh-to-watch-now-as-earnings-ai-and-biotech-catalysts-build.html","title":{"rendered":"Microcaps TOON, IGC, SURG, MDXH to Watch Now as Earnings, AI and Biotech Catalysts Build"},"content":{"rendered":"
\"Microcaps<\/a><\/div>\n

August 14, 2026 —<\/strong> Investor attention continues to focus on microcap stocks, small-cap earnings, artificial intelligence, cybersecurity, biotechnology, Alzheimer’s drug development and high-growth technology<\/strong>, with Kartoon Studios (NYSE: TOON), Cycurion (NASDAQ: CYCU), SurgePays (NASDAQ: SURG), MDxHealth (NASDAQ: MDXH) and IGC Pharma (NYSE: IGC) presenting several developing catalysts.<\/p>\n

Kartoon Studios, Inc. (NYSE: TOON)<\/strong> reported Q2 2026 revenue of approximately $5.8 million, net income of $27.0 million and EPS of approximately $0.38<\/strong>, with net income primarily reflecting a $39.2 million non-recurring litigation settlement gain<\/strong>. TOON ended the quarter with $40.5 million in cash and marketable securities and no long-term debt<\/strong>, while approximately $39.2 million of additional settlement proceeds remain in escrow, subject to legal fees and distributions. Total expenses declined 32% year-over-year<\/strong> as the company shifts toward owned intellectual property and higher-margin franchise monetization. Major catalysts include an Amazon Prime Video (NASDAQ: AMZN)<\/strong> agreement to launch Hundred Acre Wood<\/em> on February 18, 2027, the Stan Lee Universe<\/strong>, and former Activision Blizzard licensing executive Brooke Bacon<\/strong> leading consumer products and licensing.<\/p>\n

SurgePays, Inc. (NASDAQ: SURG)<\/strong> reported a significant Q2 improvement, with revenue increasing 40.7% year-over-year to $16.20 million<\/strong> and first-half revenue climbing 45.7% to $32.19 million. The company returned to GAAP profitability with $1.29 million in net income, or $0.05 per share<\/strong>. Operating income improved by approximately $10.3 million year-over-year<\/strong>, swinging from a $6.8 million operating loss to $3.5 million in operating income<\/strong>, while management expects a seventh consecutive quarter of sequential revenue growth.<\/p>\n

MDxHealth SA (NASDAQ: MDXH)<\/strong>, a urology-focused precision diagnostics company, reported Q2 revenue of $27.2 million, up 16% year-over-year<\/strong> and approximately $3.3 million sequentially from Q1. The company reported an operating loss of $5.1 million compared with $1.5 million in the prior-year quarter, primarily reflecting higher operating expenses associated with the ExoDx acquisition<\/strong>, as MDxHealth expands its position in precision diagnostics and urological cancer testing<\/strong>.<\/p>\n

IGC Pharma, Inc. (NYSE: IGC)<\/strong> is strengthening its regulatory, biostatistical, pharmaceutical-development and AI-enabled data science capabilities<\/strong> as lead Alzheimer’s drug candidate IGC-AD1<\/strong> advances toward expected Phase 2 topline results in Q4 2026<\/strong>. The upcoming clinical data represents an important milestone as the company develops potential treatments targeting Alzheimer’s disease and neurodegenerative disorders<\/strong>.<\/p>\n

With catalysts spanning Q2 earnings, Amazon streaming, artificial intelligence, cybersecurity, telecommunications growth, precision diagnostics and Phase 2 Alzheimer’s clinical trials<\/strong>, TOON, CYCU, SURG, MDXH and IGC<\/strong> are among the microcap stocks investors may be watching as the second half of 2026 progresses.<\/p>\n

 <\/p>\n

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Street Reports<\/a>
Contact Person:<\/strong> Editor
Email:<\/strong> Send Email<\/a>
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.thestreetreports.com<\/a><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

August 14, 2026 — Investor attention continues to focus on microcap stocks, small-cap earnings, artificial intelligence, cybersecurity, biotechnology, Alzheimer’s drug development and high-growth technology, with Kartoon Studios (NYSE: TOON), Cycurion<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/545048"}],"collection":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/comments?post=545048"}],"version-history":[{"count":0,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/posts\/545048\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/media?parent=545048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/categories?post=545048"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.northcarolinaheadlines.com\/news\/wp-json\/wp\/v2\/tags?post=545048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}